<DOC>
	<DOCNO>NCT02431117</DOCNO>
	<brief_summary>To evaluate suitability ( i.e . number test complete number participant complete test , variance estimate baseline change baseline value ) neurocognitive test function scale view use future multicenter , multinational clinical efficacy trial test putative cognitive enhancer individual Down syndrome age 6-30 .</brief_summary>
	<brief_title>Non-drug Study Assess Suitability Assessment Scales Japanese Individuals With Down Syndrome Aged 6-30</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Down Syndrome</mesh_term>
	<criteria>Subjects may standard trisomy 21 , Robertsonian translocation , isochromosome21 , Down syndrome reciprocal translocation mosaicism . Availability parent reliable caregiver agree accompany subject clinic visit , provide information subject 's behavior symptom . Down Syndrome subject meet clinical diagnostic criterion generalize anxiety disorder , major depressive disorder , autism spectrum disorder , attention deficit hyperactivity disorder , participate study provide stable medication least 8 week prior screen . Individuals may able comply protocol perform outcome measure due significant hear visual impairment issue judge relevant investigator .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>